Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by 294everon May 27, 2020 3:23pm

123 Views

Post# 31079513

RE:Growmax

I don't think there's brakes being put on....
Theyre just waiting for this to play out.

Bullruns companies all have common shareholders.
I think our friend Algernon could probably shed some insight to that, but quite a few anyway

No news isn't always bad news. Share price may be affected right but if there's nothing to report yet there's nothing to report. I guess we gonna find out in the coming days truly how long everybody is.

If you got shares and you can hold em my instinct tells me be patient. Some data should be reported soon!

Kinda like waiting for a chicken egg to hatch right luvhorses?

GLTA

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario